Oligodendrogliomas are a distinct subtype of gliomas frequently characterized by the 1p/19q codeletion and isocitrate dehydrogenase (IDH) gene mutations, both associated with improved therapeutic response and prolonged survival. The gene discussed is IDH1; the disease is central nervous system cancer.